Literature DB >> 20498071

Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells.

Tracie Delgado1, Patrick A Carroll, Almira S Punjabi, Daciana Margineantu, David M Hockenbery, Michael Lagunoff.   

Abstract

Kaposi's sarcoma (KS) is the most commonly reported tumor in parts of Africa and is the most common tumor of AIDS patients world-wide. KS-associated herpesvirus (KSHV) is the etiologic agent of KS. Although KS tumors contain many cell types, the predominant cell is the spindle cell, a cell of endothelial origin that maintains KSHV latency. KSHV activates many cell-signaling pathways but little is known about how KSHV alters cellular metabolism during latency. The Warburg effect, a common metabolic alteration of most tumor cells, is defined by an increase in aerobic glycolysis and a decrease in oxidative phosphorylation as an energy source. The Warburg effect adapts cells to tumor environments and is necessary for the survival of tumor cells. During latent infection of endothelial cells, KSHV induces aerobic glycolysis and lactic acid production while decreasing oxygen consumption, thereby inducing the Warburg effect. Inhibitors of glycolysis selectively induce apoptosis in KSHV-infected endothelial cells but not their uninfected counterparts. Therefore, similar to cancer cells, the Warburg effect is necessary for maintaining KSHV latently infected cells. We propose that KSHV induction of the Warburg effect adapts infected cells to tumor microenvironments, aiding the seeding of KS tumors. Additionally, inhibitors of glycolysis may provide a unique treatment strategy for latent KSHV infection and ultimately KS tumors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20498071      PMCID: PMC2890792          DOI: 10.1073/pnas.1004882107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  On respiratory impairment in cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-08-10       Impact factor: 47.728

2.  Akt stimulates aerobic glycolysis in cancer cells.

Authors:  Rebecca L Elstrom; Daniel E Bauer; Monica Buzzai; Robyn Karnauskas; Marian H Harris; David R Plas; Hongming Zhuang; Ryan M Cinalli; Abass Alavi; Charles M Rudin; Craig B Thompson
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

3.  Sirolimus for Kaposi's sarcoma in renal-transplant recipients.

Authors:  Giovanni Stallone; Antonio Schena; Barbara Infante; Salvatore Di Paolo; Antonella Loverre; Giulio Maggio; Elena Ranieri; Loreto Gesualdo; Francesco Paolo Schena; Giuseppe Grandaliano
Journal:  N Engl J Med       Date:  2005-03-31       Impact factor: 91.245

4.  Glycolysis during early infection of feline and human cells with feline leukemia virus.

Authors:  D Bardell; M Essex
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

5.  Glycolysis in chick embryo cell cultures transformed by Rous sarcoma virus.

Authors:  T L Steck; S Kaufman; J P Bader
Journal:  Cancer Res       Date:  1968-08       Impact factor: 12.701

6.  Effect of oxamate on glycolysis and respiration in sarcoma 37 ascites cells.

Authors:  J C Elwood
Journal:  Cancer Res       Date:  1968-10       Impact factor: 12.701

7.  Hypersensitization of tumor cells to glycolytic inhibitors.

Authors:  H Liu; Y P Hu; N Savaraj; W Priebe; T J Lampidis
Journal:  Biochemistry       Date:  2001-05-08       Impact factor: 3.162

Review 8.  Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.

Authors:  Lyubomir A Dourmishev; Assen L Dourmishev; Diana Palmeri; Robert A Schwartz; David M Lukac
Journal:  Microbiol Mol Biol Rev       Date:  2003-06       Impact factor: 11.056

9.  Selective down-regulation of human papillomavirus transcription by 2-deoxyglucose.

Authors:  T Maehama; A Patzelt; M Lengert; K J Hutter; K Kanazawa; H Hausen; F Rösl
Journal:  Int J Cancer       Date:  1998-05-29       Impact factor: 7.396

10.  Increased OXPHOS activity precedes rise in glycolytic rate in H-RasV12/E1A transformed fibroblasts that develop a Warburg phenotype.

Authors:  Ad J C de Groof; Mariska M te Lindert; Michiel M T van Dommelen; Min Wu; Marieke Willemse; Amy L Smift; Mike Winer; Frank Oerlemans; Helma Pluk; Jack A M Fransen; Bé Wieringa
Journal:  Mol Cancer       Date:  2009-07-31       Impact factor: 27.401

View more
  116 in total

1.  Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen and angiogenin interact with common host proteins, including annexin A2, which is essential for survival of latently infected cells.

Authors:  Nitika Paudel; Sathish Sadagopan; Sandhya Balasubramanian; Bala Chandran
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

Review 2.  The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency.

Authors:  Mary E Ballestas; Kenneth M Kaye
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

Review 3.  Lipids at the interface of virus-host interactions.

Authors:  Vineela Chukkapalli; Nicholas S Heaton; Glenn Randall
Journal:  Curr Opin Microbiol       Date:  2012-06-09       Impact factor: 7.934

Review 4.  Kaposi's sarcoma and its associated herpesvirus.

Authors:  Enrique A Mesri; Ethel Cesarman; Chris Boshoff
Journal:  Nat Rev Cancer       Date:  2010-10       Impact factor: 60.716

5.  Correlation of brain amyloid with "aerobic glycolysis": A question of assumptions?

Authors:  Michael E Phelps; Jorge R Barrio
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

Review 6.  Activation of cellular metabolism during latent Kaposi's Sarcoma herpesvirus infection.

Authors:  Michael Lagunoff
Journal:  Curr Opin Virol       Date:  2016-07-18       Impact factor: 7.090

7.  Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction.

Authors:  Xue Xue; Song You; Qiang Zhang; Yan Wu; Guo-Zhang Zou; Paul C Wang; Yu-Liang Zhao; Yan Xu; Lee Jia; Xiaoning Zhang; Xing-Jie Liang
Journal:  Mol Pharm       Date:  2012-02-13       Impact factor: 4.939

8.  Oncogenic Kaposi's Sarcoma-Associated Herpesvirus Upregulates Argininosuccinate Synthase 1, a Rate-Limiting Enzyme of the Citrulline-Nitric Oxide Cycle, To Activate the STAT3 Pathway and Promote Growth Transformation.

Authors:  Tingting Li; Ying Zhu; Fan Cheng; Chun Lu; Jae U Jung; Shou-Jiang Gao
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

9.  A CRISPR-Cas9 screen identifies mitochondrial translation as an essential process in latent KSHV infection of human endothelial cells.

Authors:  Daniel L Holmes; Daniel T Vogt; Michael Lagunoff
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-29       Impact factor: 11.205

Review 10.  Targeted Metabolic Reprogramming to Improve the Efficacy of Oncolytic Virus Therapy.

Authors:  Barry E Kennedy; Maryanne Sadek; Shashi A Gujar
Journal:  Mol Ther       Date:  2020-03-20       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.